Research Scientist Publications

Shaked, D., Beatty Moody, D. L., Rosenberger, W. F., Shao, H., Davatzikos, C., Katzel, L. I.,   Gullapalli, R. Seliger, S. L., Erus, G., Kouo, T., Evans, M. K., Zonderman, A. B, & Waldstein, S. R. (2020). Relations of socioeconomic status and race tostress-related subcortical volumes and prefrontal cortex in the HANDLS SCAN study. PLOS One, 12(5).

Leibel, D. K., Shaked, D., Moody, D. L., Liu, H. B., Weng, N., Evans, M. K., . . . Waldstein, S. R. (2020). Telomere length and cognitive function: Differential patterns across sociodemographic groups. Neuropsychology, 34(2), 186-198. doi:10.1037/neu0000601

Wright, R. S., Waldstein, S. R., Gerassimakis, C. S., Sprung, M. R., Moody, D. L., Taylor, A. D., . . . Zonderman, A. B. (2019). Multiple Influences on Cognitive Function Among Urban-Dwelling African Americans. Journal of Racial and Ethnic Health Disparities, 6(4), 851-860. doi:10.1007/s40615-019-00584-x

Moody, D. L., Chang, Y., Pantesco, E. J., Darden, T. M., Lewis, T. T., Brown, C., . . . Matthews, K. A. (2018). Everyday Discrimination Prospectively Predicts Blood Pressure Across 10 Years in Racially/Ethnically Diverse Midlife Women: Study of Women’s Health Across the Nation. Annals of Behavioral Medicine, 53(7), 608-620. doi:10.1093/abm/kay069

Moody, D. L., Leibel, D. K., Pantesco, E. J., Wendell, C. R., Waldstein, S. R., Evans, M. K., & Zonderman, A. B. (2020). Interactive Relations Across Dimensions of Interpersonal-Level Discrimination and Depressive Symptoms to Carotid Intimal-Medial Thickening in African Americans. Psychosomatic Medicine, 82(2), 234-246. doi:10.1097/psy.0000000000000765

Cabrera, L.Y., Courchesne, C., Kiss, Z., & Illes, J. (2019). Clinical Perspectives on Psychiatric Neurosurgery. Stereotactic and Functional Neurosurgery, 97(5-6), 391-398. doi:10.1159/000505080

Cabrera, L. Y. (2019). A human rights approach to low data reporting in clinical trials of psychiatric deep brain stimulation. Bioethics, 33(9), 1050-1058. doi:10.1111/bioe.12648

Kellmeyer, P., Chandler, J., Cabrera, L. Y., Carter, A., Kreitmair, K., Weiss, A., & Illes, J. (2019). Neuroethics at 15: The Current and Future Environment for Neuroethics. AJOB Neuroscience, 10(3), 104-110. doi:10.1080/21507740.2019.1632958

Cabrera, L. Y., Kelly-Blake, K., & Sidiropoulos, C. (2020). Perspectives on Deep Brain Stimulation and Its Earlier Use for Parkinson’s Disease: A Qualitative Study of US Patients. Brain Sciences, 10(1), 34. doi:10.3390/brainsci10010034

Cabrera, L. Y., Sadle, C., & Purcell, E. (2019). Neuroethical considerations of high-density electrode arrays. Nature Biomedical Engineering, 3(8), 586-589. doi:10.1038/s41551-019-0407-2

Cabrera, L. Y., & Bluhm, R. (2020). Fostering Neuroethics Integration: Disciplines, Methods, and Frameworks. AJOB Neuroscience, 11(3), 194-196. doi:10.1080/21507740.2020.1778128

Bluhm, R., & Cabrera, L.Y. (2020). Deep Brain Stimulation and Relational Agency: Negotiating Relationships. IJFAB: International Journal of Feminist Approaches to Bioethics, 13(1), 155-161. doi:10.3138/ijfab.13.1.10

Dave, A. A., & Cabrera, L. Y. (2020). Osteopathic Medical Students’ Attitudes Towards Different Modalities of Neuroenhancement: A Pilot Study. Journal of Cognitive Enhancement, 4(4), 422-433. doi:10.1007/s41465-020-00163-7

Cabrera, L. Y., Sarva, H., & Sidiropoulos, C. (2019). Perspectives on the Earlier Use of Deep Brain Stimulation for Parkinson Disease from a Qualitative Study of U.S. Clinicians. World Neurosurgery, 128, E16-E20. doi:10.1016/j.wneu.2019.03.051

Bluhm, R., Cabrera, L.Y., & Mckenzie, R. (2019). What we (Should) Talk about when we Talk about Deep Brain Stimulation and Personal Identity. Neuroethics, 13(3), 289-301. doi:10.1007/s12152-019-09396-6

Greenbaum, D., & Cabrera, L. Y. (2020). Editorial: ELSI in Human Enhancement: What Distinguishes It From Therapy? Frontiers in Genetics, 11, Article 618. doi:10.3389/fgene.2020.00618

Borrell, L. N., Rodríguez-Álvarez, E., & Dallo, F. J. (2020). Racial/ethnic inequities in the associations of allostatic load with all-cause and cardiovascular-specific mortality risk in U.S. adults. Plos One, 15(2), 14-Jan. doi:10.1371/journal.pone.0228336

Reznar, M. M., Dallo, F. J., Kurecka, A. J., Ruterbusch, J. J., Schwartz, K., & Tariq, M. (n.d.). The Burden of Chronic Health Conditions among Iraqi Refugees in Michigan. Article 16. Retrieved November 13, 2020, from

Kindratt, T. B., Atem, F., Dallo, F. J., Allicock, M., & Balasubramanian, B. A. (2020). The Influence of Patient–Provider Communication on Cancer Screening. Journal of Patient Experience, 10-Jan. doi:10.1177/2374373520924993

Kindratt, T. B., Dallo, F. J., Allicock, M., Atem, F., & Balasubramanian, B. A. (2020). The influence of patient-provider communication on cancer screenings differs among racial and ethnic groups. Preventive Medicine Reports, 18. doi:10.1016/j.pmedr.2020.101086

Clouston, S. A., Deri, Y., Diminich, E., Kew, R., Kotov, R., Stewart, C., . . . Luft, B. J. (2019). Posttraumatic stress disorder and total amyloid burden and amyloid‐β 42/40 ratios in plasma: Results from a pilot study of World Trade Center responders. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 11(1), 216-220. doi:10.1016/j.dadm.2019.01.003

Worthington, M. A., Petkova, E., Freudenreich, O., Cather, C., Holt, D., Bello, I., . . . Goff, D. C. (2020). Air pollution and hippocampal atrophy in first episode schizophrenia. Schizophrenia Research, 218, 63-69. doi:10.1016/j.schres.2020.03.001

Sean AP Clouston, Erica D Diminich, Roman Kotov, Robert H Pietrzak, Marcus Richards, Avron Spiro III, Yael Deri, Melissa Carr, Xiaohua Yang, Sam Gandy, Mary Sano, Evelyn J Bromet, Benjamin J Luft. (2019). Incidence of mild cognitive impairment in World Trade Center responders: Long-term consequences of re-experiencing the events on 9/11/2001. Journal of Alzheimer’s & dementia (Amsterdam, Netherlands). 11(4), 216-200.

Kritikos, M., Clouston, S. A., Diminich, E. D., Deri, Y., Yang, X., Carr, M., . . . Luft, B. J. (2020). Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife. Neurology and Therapy, 9(1), 159-171. doi:10.1007/s40120-020-00189-1

Garcia, M. A., Ortiz, K., Arévalo, S. P., Diminich, E. D., Briceño, E., Vega, I. E., & Tarraf, W. (2020). Age of Migration and Cognitive Function Among Older Latinos in the United States. Journal of Alzheimer’s Disease, 76, 1493-1511. doi:10.3233/jad-191296

Clouston, S., Kotov, R., Deri, Y., Pietrzak, R. H., Richards, M., Spiro, A., . . . Luft, B. (2006). Incidence Of Mild Cognitive Impairment In A Sample Of World Trade Center Responders: The Long-Term Implications Of Re-Experiencing The Event. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 11, 628-636. doi:10.1016/j.jalz.2018.06.2566

Saenz, J. L., Garcia, M. A., & Downer, B. (2018). Late life depressive symptoms and cognitive function among older Mexican adults: The past and the present. Aging & Mental Health, 24(3), 413-422. doi:10.1080/13607863.2018.1544214

Garcia, M. A., Reyes, A. M., & Rote, S. (2018). Disability and the Immigrant Health Paradox: Gender and Timing of Migration. Contextualizing Health and Aging in the Americas, 249-269. doi:10.1007/978-3-030-00584-9_12

García, C., Garcia, M. A., Chiu, C., Rivera, F. I., & Raji, M. (2018). Life Expectancies With Depression by Age of Migration and Gender Among Older Mexican Americans. The Gerontologist, 877-885. doi:10.1093/geront/gny107

Garcia, M. A., Ortiz, K., Arévalo, S. P., Diminich, E. D., Briceño, E., Vega, I. E., & Tarraf, W. (2020). Age of Migration and Cognitive Function Among Older Latinos in the United States. Journal of Alzheimer’s Disease, 1493-1511. doi:10.3233/jad-191296

Garcia, M. A., Reyes, A. M., García, C., Chiu, C., & Macias, G. (2020). Nativity and Country of Origin Variations in Life Expectancy With Functional Limitations Among Older Hispanics in the United States. Research on Aging, 42(7-8), 199-207. doi:10.1177/0164027520914512

Hayek, S. S., Reiser, J., & Leaf, D. E. (2020). Soluble Urokinase Receptor and Acute Kidney Injury. New England Journal of Medicine, 382(22), 2167-2168. doi:10.1056/nejmc2003613

Perry, D., & Hayek, S. S. (2019). Carcinoid Heart Disease. Cardiology Clinics, 37(4), 497-503. doi:10.1016/j.ccl.2019.07.014

Iversen, E., Houlind, M. B., Kallemose, T., Rasmussen, L. J., Hornum, M., Feldt-Rasmussen, B., . . . Eugen-Olsen, J. (2020). Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients. Frontiers in Cell and Developmental Biology, 8, 339. doi:10.3389/fcell.2020.00339

Hayek, S. S., Leaf, D. E., Tahaan, S. A., Raad, M., Sharma, S., & Waikar, S. S. (2020). Soluble Urokinase Receptor and Acute Kidney Injury. New England Journal of Medicine, 382(22), 416-426. doi:10.1056/nejmc2003613

Hayek S. S. (2019). How to Say Goodbye: Simple Lessons for the Cardiovascular Physician When Faced With Patient Death, Journal of J Am Coll Cardiol. 74(1), 154-156.

Kelli, H. M., Mehta, A., Tahhan, A. S., Liu, C., Kim, J. H., Dong, T. A., . . . Quyyumi, A. A. (2019). Low Educational Attainment is a Predictor of Adverse Outcomes in Patients With Coronary Artery Disease. Journal of the American Heart Association, 8(17), E013165. doi:10.1161/jaha.119.013165

Mehta, A., Desai, S. R., Ko, Y., Liu, C., Dhindsa, D. S., Nayak, A., . . . Quyyumi, A. A. (2020). Sex Differences in Circulating Soluble Urokinase‐Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease. Journal of the American Heart Association, 9(5), E015457. doi:10.1161/jaha.119.015457

Hayek, S. S., Landsittel, D. P., Wei, C., Zeier, M., Yu, A. S., Torres, V. E., . . . Reiser, J. (2019). Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology, 30(7), 1305-1313. doi:10.1681/asn.2018121227

Hayek, S. S., Leaf, D. E., & Reiser, J. (2020). Soluble Urokinase Receptor and Acute Kidney Injury. New England Journal of Medicine, 382(22), 2167-2168. doi:10.1056/nejmc2003613

Feroze, R. A., Leya, J., Herron, T., & Hayek, S. S. (2020). Clinical and Research Tools for the Study of Cardiovascular Effects of Cancer Therapy. Journal of Cardiovascular Translational Research, 13(3), 417-430. doi:10.1007/s12265-020-10030-7

Rovina, N., Akinosoglou, K., Eugen-Olsen, J., Hayek, S., Reiser, J., & Giamarellos-Bourboulis, E. J. (2020). Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. Critical Care, 24(1), 187. doi:10.1186/s13054-020-02897-4

Lv, L., Wang, F., Wu, L., Wang, J., Cui, Z., Hayek, S. S., . . . Zhao, M. (2018). Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease. Nephrology Dialysis Transplantation, 35(3), 465-470. doi:10.1093/ndt/gfy265

Ganatra, S., Carver, J. R., Hayek, S. S., Ky, B., Leja, M. J., Lenihan, D. J., . . . Liu, J. E. (2019). Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart. Journal of the American College of Cardiology, 74(25), 3153-3163. doi:10.1016/j.jacc.2019.10.049